Stella Diagnostics: Joe Abdo, David Seaburg
Esophageal disease diagnostic company Stella Diagnostics has appointed David Seaburg as CEO and Joe Abdo as CSO, a newly created position in the company. Seaburg is currently a member of the firm's board of directors and most recently served as president and CEO of biotechnology company PolarityTE. He also served as president of corporate development at the company and was on the board of directors. Before PolarityTE, Seaburg was the managing director and head of sales trading at investment bank Cowen.
Abdo is currently the CEO of Stella Diagnostics and previously served as the senior director of clinical and translational science at PolarityTE. He was also a clinical researcher at Creighton University School of Medicine.